Literature DB >> 22208529

Multiple, ligand-dependent routes from the active site of cytochrome P450 2C9.

Vlad Cojocaru1, Peter J Winn, Rebecca C Wade.   

Abstract

The active site of liver-specific, drug-metabolizing cytochrome P450 (CYP) monooxygenases is deeply buried in the protein and is connected to the protein surface through multiple tunnels, many of which were found open in different CYP crystal structures. It has been shown that different tunnels could serve as ligand passage routes in different CYPs. However, it is not understood whether one CYP uses multiple routes for substrate access and product release and whether these routes depend on ligand properties. From 300 ns of molecular dynamics simulations of CYP2C9, the second most abundant CYP in the human liver we found four main ligand exit routes, the occurrence of each depending on the ligand type and the conformation of the F-G loop, which is likely to be affected by the CYP-membrane interaction. A non-helical F-G loop favored exit towards the putative membrane-embedded region. Important protein features that direct ligand exit include aromatic residues that divide the active site and whose motions control access to two pathways. The ligands interacted with positively charged residues on the protein surface through hydrogen bonds that appear to select for acidic substrates. The observation of multiple, ligand-dependent routes in a CYP aids understanding of how CYP mutations affect drug metabolism and provides new possibilities for CYP inhibition.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22208529     DOI: 10.2174/138920012798918462

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  9 in total

1.  The dynamics of camphor in the cytochrome P450 CYP101D2.

Authors:  Shabana Vohra; Maria Musgaard; Stephen G Bell; Luet-Lok Wong; Weihong Zhou; Philip C Biggin
Journal:  Protein Sci       Date:  2013-08-12       Impact factor: 6.725

Review 2.  Predicting drug metabolism: experiment and/or computation?

Authors:  Johannes Kirchmair; Andreas H Göller; Dieter Lang; Jens Kunze; Bernard Testa; Ian D Wilson; Robert C Glen; Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2015-04-24       Impact factor: 84.694

3.  Molecular basis of P450 OleTJE: an investigation of substrate binding mechanism and major pathways.

Authors:  Juan Du; Lin Liu; Li Zhong Guo; Xiao Jun Yao; Jian Ming Yang
Journal:  J Comput Aided Mol Des       Date:  2017-03-25       Impact factor: 3.686

4.  A Hidden Active Site in the Potential Drug Target Mycobacterium tuberculosis dUTPase Is Accessible through Small Amplitude Protein Conformational Changes.

Authors:  Anna Lopata; Ibolya Leveles; Ábris Ádám Bendes; Béla Viskolcz; Beáta G Vértessy; Balázs Jójárt; Judit Tóth
Journal:  J Biol Chem       Date:  2016-11-04       Impact factor: 5.157

5.  Escape of a Small Molecule from Inside T4 Lysozyme by Multiple Pathways.

Authors:  Ariane Nunes-Alves; Daniel M Zuckerman; Guilherme Menegon Arantes
Journal:  Biophys J       Date:  2018-03-13       Impact factor: 4.033

6.  Incorporation of charged residues in the CYP2J2 F-G loop disrupts CYP2J2-lipid bilayer interactions.

Authors:  Daniel R McDougle; Javier L Baylon; Daryl D Meling; Amogh Kambalyal; Yelena V Grinkova; Jared Hammernik; Emad Tajkhorshid; Aditi Das
Journal:  Biochim Biophys Acta       Date:  2015-07-30

7.  Ligand tunnels in T. brucei and human CYP51: Insights for parasite-specific drug design.

Authors:  Xiaofeng Yu; Prajwal Nandekar; Ghulam Mustafa; Vlad Cojocaru; Galina I Lepesheva; Rebecca C Wade
Journal:  Biochim Biophys Acta       Date:  2015-10-19

8.  Differing Membrane Interactions of Two Highly Similar Drug-Metabolizing Cytochrome P450 Isoforms: CYP 2C9 and CYP 2C19.

Authors:  Ghulam Mustafa; Prajwal P Nandekar; Neil J Bruce; Rebecca C Wade
Journal:  Int J Mol Sci       Date:  2019-09-04       Impact factor: 5.923

9.  Massively parallel characterization of CYP2C9 variant enzyme activity and abundance.

Authors:  Clara J Amorosi; Melissa A Chiasson; Matthew G McDonald; Lai Hong Wong; Katherine A Sitko; Gabriel Boyle; John P Kowalski; Allan E Rettie; Douglas M Fowler; Maitreya J Dunham
Journal:  Am J Hum Genet       Date:  2021-07-26       Impact factor: 11.025

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.